Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.103834 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Liangpan Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, 362002, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Glycosphingolipids, Phospholipids. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a prevalent malignancy with high morbidity and mortality rates globally. Advances in single-cell sequencing technology have enabled comprehensive analyses of tumor cells at single-cell resolution, providing valuable insights into the molecular mechanisms underlying CRC initiation and progression. In this study, we integrated single-cell sequencing data with the TCGA database to identify key molecular pathways involved in CRC pathogenesis. Our analysis revealed that dysregulation of phospholipid metabolism, particularly sphingolipid metabolism, plays a crucial role in CRC development. Specifically, we observed aberrant expression of genes involved in sphingolipid biosynthesis and degradation, as well as altered levels of various sphingolipid metabolites in CRC cells. Furthermore, we identified several potential therapeutic targets, including SMPD1, GLTP, B3GALT4, and ST8SIA6, within the sphingolipid metabolism pathway that could be exploited for the development of novel CRC treatments. Overall, our findings provide novel insights into the molecular mechanisms underlying CRC and highlight the importance of targeting phospholipid metabolism, specifically sphingolipid metabolism, as a potential therapeutic strategy for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, 362002, China.
Zitieren
APA
Shi, L., Mao, N., Zheng, Z., Liu, J., Zhou, H., Hou, J., & Su, Y. (2025). Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.103834
Vancouver
Shi L, Mao N, Zheng Z, Liu J, Zhou H, Hou J, et al. Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.103834
BibTeX
@article{Shi2025,
author = {Shi, Liangpan and Mao, Nanqi and Zheng, Zhihua and Liu, Jiangrui and Zhou, Hao and Hou, Jianbin and Su, Yibin},
title = {Glycosphingolipids-Dependent Phospholipid Metabolism Enhances Cancer Initiation and Progression through SMPD1/GLTP/B3GALT4/ST8SIA6 Signaling Axis: A Novel Therapeutic Target},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.103834}
}
EUVIMED